Exelixis (EXEL) Divestments (2010 - 2015)
Exelixis (EXEL) recorded quarterly Divestments of $95000.0 in Q1 2015, down 88.12% quarter-over-quarter from $800000.0 in Q3 2014.
Exelixis (EXEL) Divestments (2010 - 2015) Analysis & Trends
Exelixis' Divestments history runs 3 years deep, the most recent figure standing at $95000.0 for Q1 2015.
- In Q1 2015, Divestments changed N/A year-over-year to $95000.0; the TTM figure through Jun 2015 stood at $895000.0 (changed N/A YoY), while the FY2014 annual figure was $838000.0, changed N/A from the prior year.
- Divestments was $95000.0 for Q1 2015 at Exelixis, down from $800000.0 in the prior quarter.
- In the past five years, Divestments ranged from a high of $800000.0 in Q3 2014 to a low of $95000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Exelixis | 13.71 Bn | 12.93 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 95,000.00 |
| Sep 30, 2014 | 800,000.00 |
| Dec 31, 2010 | 400,000.00 |